Axcelis Technologies (NASDAQ:ACLS)
Q2 2014 Earnings Conference Call
August 4, 2014 5:00 p.m. ET
Mary Puma – Chairman and CEO
Doug Lawson – EVP, Corporate Marketing and Strategy
Kevin Brewer – EVP and CFO
The following audio is from a conference call that will begin on August 04, 2014 at 17:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.
Complete Story »
NeuroMetrix, Inc. (Nasdaq: NURO)
announced that its wearable technology for treatment of chronic pain received 510(k) clearance (K140333) from the U.S. Food and Drug Administration (FDA) for over-the-counter use.
TherapeuticsMD, Inc. (NYSE: TXMD)
New Outperform rating, $34 price target at FBR Capital
Axcelis Technologies (NASDAQ: ACLS)
announced that multiple systems planned for late June shipment pushed out of the second...
By Markus Aarnio:
Axcelis Technologies (ACLS) designs, manufactures, and services ion implantation, dry strip, and other processing equipment used in the fabrication of semiconductor chips worldwide.
(click to enlarge)
Axcelis Technologies (ACLS)
Q1 2014 Earnings Call
May 06, 2014 5:00 pm ET
Mary G. Puma - Chairman, Chief Executive Officer and President
Doug Lawson - Executive Vice President of Corporate Marketing and Strategy
The following audio is from a conference call that will begin on May 06, 2014 at 17:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.
Complete Story »
Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced it received a follow-on order for the Optima HDx high current implanter from one of the world's leading...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.